Author:
Shibuya Kimiyuki,Miura Toru,Ohgiya Tadaaki,Omichi Kozo,Tsunenari Yoshihiko
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference32 articles.
1. Discovery of clinical candidate 2-(4-(2-((1H-benzo[d]imidazol-2-yl)-thio)ethyl)piperazin-1-yl)-N-(6-methyl-2,4-bis(methylthio)pyridin-3-yl)acetamide hydrochloride [K-604], an aqueous soluble acyl-CoA:cholesterol O-acyltransferase (ACAT/SOAT)-1 inhibitor;Shibuya;J. Med. Chem.,2018
2. Shibuya, K.; Kawamine, K.; Sato, Y.; et al. Novel cyclic diamine compounds and medicine containing the same. WO1998054153, May 26, 1998.
3. Inhibiting ACAT1/ SOAT1 in microglia stimulates autophagy-mediated lysosomal proteolysis and increases Aβ1-42 clearance;Shibuya;J Neurosci,2014
4. Induction of apoptosis and necroptosis by 24(S)-hydroxycholesterol is dependent on activity of acyl-CoA:cholesterol acyltransferase 1;Yamanaka;Cell Death Dis,2014
5. ACAT1/SOAT1 as a therapeutic target for Alzheimer’s disease;Shibuya;Future Med Chem,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献